Intra-articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone

Scandinavian Journal of Rheumatology, Supplement

Volumn 33, Issue 119, 2004, Pages 51-54

  Samborski, W ^a   Stratz, T ^b   Mackiewicz, S ^a   Muller W ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Hochrhein Inst fur Rehab Forsch   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; MEPREDNISONE; SEROTONIN 3 ANTAGONIST; TROPISETRON; INDOLE DERIVATIVE; METHYLPREDNISOLONE; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE; FEMALE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; KNEE ARTHRITIS; MALE; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE; ARTHRITIS; ARTICLE; COMPARATIVE STUDY; DRUG ANTAGONISM; INTRAARTICULAR DRUG ADMINISTRATION; KNEE OSTEOARTHRITIS; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; INJECTIONS, INTRA-ARTICULAR; MALE; METHYLPREDNISOLONE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 4444254988     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410007050     Document Type: Conference Paper

References (10)

1. Otte P. Die Pathophysiologie der aktivierten Arthrose und die Angriffspunkte der medikamentösen Therapie. Orthopäd. Praxis 1971;9:207-13.
2. Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCITIT). Ann Rheum Dis 2003;62:1145-55.
3. Fiegel G. Kortikoid-Nebenwirkungen. Schattauer/Stuttgart 1979.
4. Stratz T, Farber L, Muller W. Local treatment of tendinopathies. A comparison between tropisetron and depot corticosteroids combined with local anesthetics. Scand J Rheumatol 2002;31:1-5.
5. 3 receptor antagonist in trigger point therapy. (In preparation).
6. 3-Rezeptorantagonisten als neues therapeutisches Prinzip in der Rheumatologie? Z Rheumatol 2001;60:47-8.
7. 3-Rezeptorantagonisten als neues therapeutisches Prinzip in der Rheumatologie? Z Rheumatol 2001;60:47-8.
8. 3 receptor antagonists in various rheumatic diseases - a clue to the mechanism of action of these agents in fibromyalgia? Scand J Rheumatol 2000;29 Suppl 113:66-71.
9. Stratz T, Urbaniak M, Lacki JK, Mackiewicz S, Reichelt A, Muller W. Intra-articular injection of tropisetron in osteoarthrosis with inflammatory reactions. Ann Rheum Dis 2002;61 Suppl 1:420.
10. Muller W, Stratz T. 5-HT3-receptor-antagonists in therapy of rheumatic diseases. Z. Rheumatol 2003;62:39-41.